Vogt-Koyanagi-Harada Syndrome

We studied 51 patients who developed Vogt-Koyanagi-Harada (V-K-H) syndrome after corticosteroid therapy. The final visual acuity was better than 6/15 (20/50) in 50%, and less than 6/60 (20/200) in 25% of the patients. The severity and extraocular manifestations of this disease also appeared to be le...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of ophthalmology 1977-05, Vol.83 (5), p.735-740
Hauptverfasser:	Ohno, Shigeaki, Char, Devron H., Kimura, Samuel J., Richard O'Connor, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adrenal Cortex Hormones - therapeutic use Adult Central Nervous System Diseases - etiology Child Female Humans Male Middle Aged Pigmentation Disorders - diagnosis Pigmentation Disorders - drug therapy Uveitis - diagnosis Uveitis - drug therapy Uveomeningoencephalitic Syndrome - diagnosis Uveomeningoencephalitic Syndrome - drug therapy Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We studied 51 patients who developed Vogt-Koyanagi-Harada (V-K-H) syndrome after corticosteroid therapy. The final visual acuity was better than 6/15 (20/50) in 50%, and less than 6/60 (20/200) in 25% of the patients. The severity and extraocular manifestations of this disease also appeared to be less than observed in patients before the clinical use of corticosteroids. Corticosteroid therapy probably altered the clinical picture in this disease, although other possibilities, including a skewed patient population, may account for these differences.
ISSN:	0002-9394 1879-1891
DOI:	10.1016/0002-9394(77)90142-8